Oric Pharmaceuticals Inc (ORIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -77,259 | -35,767 | -129,468 | -98,963 | -66,376 |
| Depreciation Amortization | 987 | 432 | -1,080 | -1,160 | -861 |
| Other Working Capital | -1,760 | -4,001 | -5,459 | -7,123 | -9,266 |
| Other Operating Activity | 13,989 | 6,898 | 25,037 | 18,759 | 13,128 |
| Operating Cash Flow | $-64,043 | $-32,438 | $-110,970 | $-88,487 | $-63,375 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -5,753 | -17,973 | -147,319 | -164,530 | -54,030 |
| PPE Investments | -358 | -2 | -712 | -485 | -450 |
| Investing Cash Flow | $-6,111 | $-17,975 | $-148,031 | $-165,015 | $-54,480 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 62,961 | 62,133 | 247,661 | 246,161 | 134,969 |
| Other Financing Activity | -993 | -993 | -2,397 | -2,397 | -656 |
| Financing Cash Flow | $61,968 | $61,140 | $245,264 | $243,764 | $134,313 |
| Beginning Cash Position | 46,160 | 46,160 | 59,897 | 59,897 | 59,897 |
| End Cash Position | 37,974 | 56,887 | 46,160 | 50,159 | 76,355 |
| Net Cash Flow | $-8,186 | $10,727 | $-13,737 | $-9,738 | $16,458 |
| Free Cash Flow | |||||
| Operating Cash Flow | -64,043 | -32,438 | -110,970 | -88,487 | -63,375 |
| Capital Expenditure | -358 | -2 | -712 | -485 | -450 |
| Free Cash Flow | -64,401 | -32,440 | -111,682 | -88,972 | -63,825 |